Does TEPROTUMUMAB Cause Endocrine ophthalmopathy? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Endocrine ophthalmopathy have been filed in association with TEPROTUMUMAB (TEPEZZA). This represents 12.7% of all adverse event reports for TEPROTUMUMAB.
19
Reports of Endocrine ophthalmopathy with TEPROTUMUMAB
12.7%
of all TEPROTUMUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Endocrine ophthalmopathy From TEPROTUMUMAB?
Of the 19 reports, 1 (5.3%) required hospitalization.
Is Endocrine ophthalmopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPROTUMUMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does TEPROTUMUMAB Cause?
Deafness (21)
Deafness bilateral (16)
Hyperglycaemia (15)
Muscle spasms (14)
Deafness neurosensory (12)
Therapy partial responder (12)
Tinnitus (11)
Diarrhoea (10)
Drug ineffective (10)
Alopecia (9)
What Other Drugs Cause Endocrine ophthalmopathy?
TEPROTUMUMAB-TRBW (245)
PREDNISONE (85)
ALEMTUZUMAB (55)
SODIUM IODIDE I-131 (43)
LEVOTHYROXINE (27)
METHOTREXATE (26)
TOCILIZUMAB (24)
ABATACEPT (22)
ATORVASTATIN (21)
SIMVASTATIN (20)
Which TEPROTUMUMAB Alternatives Have Lower Endocrine ophthalmopathy Risk?
TEPROTUMUMAB vs TEPROTUMUMAB-TRBW
TEPROTUMUMAB vs TERAZOSIN
TEPROTUMUMAB vs TERAZOSIN\TERAZOSIN
TEPROTUMUMAB vs TERBINAFINE
TEPROTUMUMAB vs TERBINAFINE\TERBINAFINE